Head-To-Head Contrast: 908 Devices (MASS) and Its Rivals

908 Devices (NASDAQ:MASSGet Rating) is one of 28 public companies in the “Measuring & controlling devices, not elsewhere classified” industry, but how does it compare to its rivals? We will compare 908 Devices to related companies based on the strength of its dividends, profitability, valuation, institutional ownership, risk, analyst recommendations and earnings.

Analyst Ratings

This is a summary of recent ratings and price targets for 908 Devices and its rivals, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
908 Devices 0 0 1 0 3.00
908 Devices Competitors 154 689 953 28 2.47

908 Devices presently has a consensus price target of $30.00, suggesting a potential upside of 113.52%. As a group, “Measuring & controlling devices, not elsewhere classified” companies have a potential upside of 27.50%. Given 908 Devices’ stronger consensus rating and higher probable upside, equities research analysts clearly believe 908 Devices is more favorable than its rivals.

Institutional and Insider Ownership

79.2% of 908 Devices shares are held by institutional investors. Comparatively, 61.0% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are held by institutional investors. 51.1% of 908 Devices shares are held by insiders. Comparatively, 16.1% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares 908 Devices and its rivals top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
908 Devices $42.21 million -$22.17 million -15.97
908 Devices Competitors $2.66 billion $435.24 million 11.14

908 Devices’ rivals have higher revenue and earnings than 908 Devices. 908 Devices is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.


This table compares 908 Devices and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
908 Devices -56.68% -15.20% -12.07%
908 Devices Competitors -3,288.70% 4.83% 1.80%

Risk and Volatility

908 Devices has a beta of 1.59, meaning that its stock price is 59% more volatile than the S&P 500. Comparatively, 908 Devices’ rivals have a beta of 1.03, meaning that their average stock price is 3% more volatile than the S&P 500.


908 Devices beats its rivals on 7 of the 13 factors compared.

908 Devices Company Profile (Get Rating)

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.